Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes (Q57612974)
scientific article published on 21 August 2011
Language:
(P31) (Q13442814)
(P50) (Q57413861)
(Q56943308)
(Q56426736)
(P304) 2095-2102
(P407) (Q1860)
(P433) 12
(P478) 70
(P577) Sunday, August 21, 2011
(P921) (Q181600)
(Q1771331)
(P1433) (Q4767876)
(P1476) "Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes" (language: en)
(P2093) Jasmin B Kuemmerle-Deschner
R Cartwright
P N Hawkins
T A Tran
J Hoyer
M Gattorno
A Gul
J Smith
K S Leslie
S Jiménez
S Morell-Dubois
N Davis
N Patel
A Widmer
R Preiss
other details
description scientific article published on 21 August 2011

External Links